Welcome to AiCuris: The Powerhouse for Anti-Infectives

AiCuris (from 'Anti-infective Cures') is a pharmaceutical company focused exclusively on the discovery, research and development of novel antiviral and antibacterial agents for the treatment of severe and potentially life-threatening infectious diseases.




Founded in 2006 from Bayer's virology and bacteriology research divisions, AiCuris has a broad and innovative pipeline of novel anti-infectives and a team of internationally regarded scientists and drug developers. With its focus on specialist markets with high medical need, the company is perfectly positioned for growth and success.

Partnering with AiCuris



Interested in our projects?

AiCuris is constantly evaluating strategic partnerships and collaboration oppor-
tunities with Biotech or Pharmaceutical companies.


Read more ...

BEAM Position Paper




BEAM Position Paper
The BEAM Alliance (Biopharmaceutical companies from Europe innovating in Anti-Microbial resistance research) announced its position paper.   

Read more ...


Job Opportunities

Join AiCuris and its quest for novel Anti-Infectives
We offer an exciting and challenging working enviroment in an innovative company with a world-class  R&D Portfolio.